Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Anim Reprod Sci ; 63(1-2): 27-39, 2000 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-10967238

RESUMO

Bovine preantral follicles (40-100 microm diameter at collection) were collected from ovaries of slaughtered cows and cultured in vitro with one of the four treatments: follicle stimulating hormone (FSH; 100 ng/ml) alone; FSH plus epidermal growth factor (EGF; 100 ng/ml); FSH plus insulin-transferrin-selenium (ITS; +1%) or FSH plus hypoxanthine (4 mM) in tissue culture medium (TCM 199) supplemented with 10% fetal calf serum (FCS), 0.1 mg/ml sodium pyruvate, 100 IU/ml of penicillin and 100 microg/ml streptomycin. The control culture medium was TCM 199 with supplements without any treatments. Follicles of each size were cultured separately in groups of one to three in 24-well multidishes each containing 500 microl of the appropriate culture medium. Culture commenced at follicle recovery (day 1) and continued for 10 days (harvested on day 11). In each case, half the medium was removed and replaced by fresh medium every third day. Follicle diameters were recorded on days 1, 5 and 11 of the experiment. At the end of the 10-day culture period, half of the follicles were stained with trypan blue to assess their potential viability and half were stained with bisbenzimide plus propidium iodine to estimate various morphological features of the follicles. Follicles of all initial sizes, on all culture treatments, increased in diameter during in vitro cultures with the greatest increases, both in absolute and proportional size, occurring between days 1 and 5 of culture. All of the culture medium supplements caused greater increases in follicle diameters than control medium at both days 5 and 11 of culture for all initial sizes of follicles (p<0.01). The most effective culture supplements for follicles of 40-, 60- and 80-microm initial diameter were FSH alone and FSH+EGF. The size of these follicles at both days 5 and 11 of culture on both the treatments was significantly larger (p<0.01) than follicles cultured in the presence of the other two supplementary treatments. The growth of follicles of 100-microm initial diameter did not differ between culture medium supplements. None of the culture media caused follicle size to increase to the initial diameters of the next larger size category during the 10 days of culture although follicles of 100-microm diameter achieved a diameter of 120 microm, after 4 days of culture. The overall follicular viability and morphology were better with treatments than the controls in all cases; however, there was no significant difference (p>0.05) among them. From this experiment, FSH and FSH plus EGF may be recommended for in vitro culture of smaller (40, 60 and 80 microm) follicles.


Assuntos
Folículo Ovariano/fisiologia , Animais , Bovinos , Meios de Cultura , Técnicas de Cultura , Fator de Crescimento Epidérmico/farmacologia , Feminino , Hormônio Foliculoestimulante/farmacologia , Hipoxantina/farmacologia , Insulina/farmacologia , Folículo Ovariano/anatomia & histologia , Selênio/farmacologia , Transferrina/farmacologia
2.
Br Vet J ; 150(1): 85-92, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-8025840

RESUMO

A monoclonal antibody against gonadotropin releasing hormone (GnRH)-BSA was used in the development of a sensitive enzyme immunoassay of GnRH in the canine hypothalamus and in plasma. The method had a limit of detection of 4 pg per sample. The intra- and interassay coefficients of variation were < 7.3% and < 11.0%, respectively. Acid extracts of hypothalamus produced a dose response curve which was parallel to that obtained with the synthetic GnRH standard. Checking cross reactivity of various fragments of GnRH revealed that the antibody was formed predominantly against the C-terminal end of GnRH. Thyrotropin-releasing hormone and other hypothalamic hormones did not appear to influence the assay. In male dogs, hypothalamic GnRH levels increased with age up to 4 months, then fell to a plateau from 6 months to 2 years. The time required for a 50% reduction in plasma levels following intravenous administration of synthetic GnRH to five adult male dogs was 2.2 +/- 0.1 (SEM) min.


Assuntos
Envelhecimento/metabolismo , Anticorpos Monoclonais , Cães/metabolismo , Hormônio Liberador de Gonadotropina/análise , Hipotálamo/química , Sequência de Aminoácidos , Animais , Hormônio Liberador de Gonadotropina/sangue , Hormônio Liberador de Gonadotropina/química , Hormônio Liberador de Gonadotropina/farmacocinética , Meia-Vida , Técnicas Imunoenzimáticas , Masculino , Dados de Sequência Molecular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA